Cargando…
3D Pharmacophore-Based Discovery of Novel K(V)10.1 Inhibitors with Antiproliferative Activity
SIMPLE SUMMARY: A novel structural class of inhibitors of the voltage-gated potassium channel K(V)10.1 was discovered by a ligand-based drug design method using a 3D pharmacophore model. The virtual screening hit compound ZVS-08 inhibited the channel in a voltage-dependent manner consistent with the...
Autores principales: | Toplak, Žan, Hendrickx, Louise Antonia, Gubič, Špela, Možina, Štefan, Žegura, Bojana, Štern, Alja, Novak, Matjaž, Shi, Xiaoyi, Peigneur, Steve, Tytgat, Jan, Tomašič, Tihomir, Pardo, Luis A., Mašič, Lucija Peterlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002023/ https://www.ncbi.nlm.nih.gov/pubmed/33808994 http://dx.doi.org/10.3390/cancers13061244 |
Ejemplares similares
-
New Diarylamine K(V)10.1 Inhibitors and Their Anticancer Potential
por: Gubič, Špela, et al.
Publicado: (2022) -
Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K(V)10.1 Pore Blockers
por: Toplak, Žan, et al.
Publicado: (2021) -
Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity
por: Gubič, Špela, et al.
Publicado: (2022) -
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14, 2595
por: Gubič, Špela, et al.
Publicado: (2023) -
Discovery of K(V)1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges
por: Gubič, Špela, et al.
Publicado: (2021)